ecancer

Avelumab and axitinib vs sunitinib in treating advanced renal cell carcinoma

Dr Robert J. Motzer - Memorial Sloan-Kettering Cancer Center, New York, USA

21 Oct 2018

Survival results from STAMPEDE, radiotherapy for prostate cancer

Dr Chris C. Parker - The Royal Marsden, London, UK

21 Oct 2018

Bispecific T-cell engaging therapy for adult ALL

Prof Max Topp - University of Würzburg, Würzburg, Germany

18 Oct 2018

The promise of immunotherapy in head and neck, and prostate cancer

Dr Luis Larrea - NISA, Valencia, Spain

7 Aug 2018

The 'My Health Avatar' app for iManageCancer

Prof Feng Dong - University of Bedfordshire, Luton, UK

6 Aug 2018

MyPathway study: a novel precision oncology multiple basket trial

Dr Mary S. Beattie - Genentech, USA

6 Jul 2018

Precision CAR T cell therapeutics

Prof Carl H. June - Perelman School of Medicine, Philadelphia, USA

6 Jul 2018

Editor's Choice for June 2018

Prof Gordon McVie - Founding Editor, ecancer

4 Jul 2018

ASCO 2018 conference round up

Dr Bishal Gyawali and Will Davies

24 Jun 2018

Phase II results of olaparib and abiraterone for mCRPC

Prof Noel Clarke - Salford Royal NHS Foundation Trust, Salford, UK

4 Jun 2018

Phase III results of PROSPECT study for metastatic, castration-resistant prostate cancer

Dr James Gulley - Center for Cancer Research, Washington, USA

4 Jun 2018

Sunitinib with or without surgery for metastatic renal cell carcinoma

Prof Arnaud Mejean - Paris Descartes University, Paris, France

3 Jun 2018

More from ecancer